Is Vaccine Brand Hesitancy on the Rise? Expert Provides Answers

Millions of doses of the Johnson & Johnson vaccine have been delivered this week, but officials are concerned that the lower efficacy estimate will lead to a misconception that it is a lesser option. Johnson & Johnson’s vaccine has a 66% efficacy rate compared to 94% for Moderna and 95% for Pfizer – partly as they were not all tested in equal settings, or at the same time. Dr. John Torres helps to clarify the different vaccine efficacies, what those numbers mean and why getting the first vaccine available to you is the best option.